Tamoxifen Citrate (Nolvadex) Powder (54965-24-1)
Name: Tamoxifen Citrate
Alias: TAM; Nolvadex
Purity:99%min
CAS : 54965-24-1
Appearance: white crystalline powder
Molecular Formula: C26H29NO.C6H8O7
Molecular weight: 563.64
Half Life:Active half-life 5-7 hours
Usage:estrogen antagonist, antineoplastic
Tamoxifen Citrate (Nolvadex) Description:
Tamoxifen citrate is most often referred to as Nolvadex by Bodybuilders.it is not a steroid, rather a selective Estrogen blocker. While Nolvadex doesn’t prevent the build-up of Estrogen in the body, it does prevent it from acting on certain receptors.Tamoxifen Citrate has been used medically for decades and has been highly successful in breast cancer treatment. It is also a medication that is used by many anabolic steroid users, but it is not a steroid.
This is a drug steroid users will sometimes use during steroid use to help with estrogenic related side effects brought on by specific steroids. This has obvious benefits to bodybuilders, because this is the area in which gyno occurs during the use of aromatizing steroids such as testosterone.Nolvadex will reduce water retention may result in the user agreeing that gains are less, since weight gain is less, thus reinforcing the bias.
Tamoxifen Citrate (Nolvadex) Application:
Nolvadex tablets are indicated for the treatment of axillary node negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection and breast irradiation. Data are insufficient to predict which women are most likely to benefit and to determine if Tamoxifen Citrate Tablets provide any benefit in women with tumors less than 1 cm.
Nolvadex indicated for the treatment of node-positive breast cancer in postmenopausal women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. In some Tamoxifen Citrate adjuvant studies, most of the benefit to date has been in the subgroup with 4 or more positive axillary nodes.
Tamoxifen Citrate (Nolvadex) COA:
Test |
Analysis Standard |
Results |
Characteristics |
White crystalline powder |
conforms |
Assay |
99 ~ 101.0% |
99.51% |
Loss on drying |
≤ 0.5% |
0.24% |
Identification |
IR, UV conform |
conforms |
Residue on ignition |
≤ 0.2% |
0.06% |
Iron |
≤ 0.005% |
0.0016% |
Heavy metals |
≤ 0.001% |
0.0006% |
Related substances |
Total: ≤ 1.0% |
0.37% |
|
Individual: ≤ 0.5% |
0.17% |
E-isomer |
≤ 0.3% |
0.20% |
Organic volatile impurities |
conform |
conform |
Tamoxifen Citrate (Nolvadex) Benefits:
1 . Estrogen blocker
2 . Boosts natural testosterone production
3 . Lesser risk of developing “gyno”
4 . Promotes liver health
Tamoxifen Citrate (Nolvadex) Dosing information:
1)Usual Adult Dose for Breast Cancer:
For the treatment of metastatic breast cancer in women and men:
20 to 40 mg orally Dosages greater than 20 mg should be given in divided doses (morning and evening).
For the treatment of women with Ductal Carcinoma in Situ, following breast surgery and radiation:
20 mg orally daily for 5 years.
To reduce the incidence of breast cancer in women at high risk for breast cancer:
20 mg orally daily for 5 years.
2)Usual Adult Dose for Breast Cancer – Adjuvant:
For the treatment of node-positive breast cancer in postmenopausal women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation:
10 mg orally 2 to 3 times a day for 5 years.
3)Usual Adult Dose for Breast Cancer – Palliative:
10 to 20 mg orally twice a day
A beneficial response may not be evident for several months after initiation of therapy.
4)Usual Pediatric Dose for McCune-Albright Syndrome:
For use in girls age 2 to 10 years with McCune-Albright Syndrome and precocious puberty:
20 mg once a day. The duration of treatment is up to 12 months.
5)Usual Pediatric Dose for Precocious Puberty:
For use in girls age 2 to 10 years with McCune-Albright Syndrome and precocious puberty:
20 mg once a day. The duration of treatment is up to 12 months.
Tamoxifen Citrate (Nolvadex) Formula:
Powder: per 1 gram of Tamoxifen Citrate
Produces: Highest concentration made – 20 mg/ml
Requirements:
1 gram of Tamoxifen Citrate
1 beaker suitable for holding the volume of liquids
19.6 ml of Glycerol
29.4 ml of 190 Proof Grain Alcohol
Powder: per 1 gram of Tamoxifen Citrate
Produces: Highest concentration made – 20 mg/ml
Requirements:
1 gram of Tamoxifen Citrate
1 beaker suitable for holding the volume of liquids
9.8 ml of PEG 600
39.2 ml of 190 Proof Grain Alcohol |